| 摘要 |
The present invention relates to novel sulfamoyl-phenyl-ureido compounds having the formula (I)wherein R, R, R, R, Rand X are as defined in the claims, or pharmaceutically acceptable salts thereof which are suitable for the therapy of infections caused by protozoa and in particular uncomplicated or severe malaria caused by plasmodia. |
